[Federal Register Volume 70, Number 187 (Wednesday, September 28, 2005)]
[Notices]
[Pages 56724-56725]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 05-19377]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


Notice of Meeting; Interagency Autism Coordinating Committee

    The National Institutes of Health (NIH) hereby announces a meeting 
of the Interagency Autism Coordinating Committee to be held on November 
18, 2005, on the NIH campus in Bethesda, Maryland.
    The Children's Health Act of 2000 (Pub. L. 106-310), Title I, 
Section 104, mandated the establishment of an Interagency Autism 
Coordinating Committee (IACC) to coordinate autism research and other 
efforts within the Department of Health and Human Services (HHS). In 
April 2001, the HHS Secretary delegated the authority to establish the 
IACC to the NIH. The National Institute of Mental Health (NIMH) at the 
NIH has been designated the lead for this activity.
    The IACC meeting will be open to the public, with attendance 
limited to space available. Individuals who plan to attend and need 
special assistance, such as sign language interpretation or other 
reasonable accommodations, should notify the contact person listed 
below in advance of the meeting.

    Name of Committee: Interagency Autism Coordinating Committee.
    Date: November 18, 2005.
    Time: 9 a.m.-4:30 p.m.
    Agenda: Discussion of autism activities across Federal agencies.
    Place: National Institutes of Health, 31 Center Drive, Building 
31, Conference Room 10 (6th floor), Bethesda, Maryland 20892.
    Contact Person: Ann Wagner, Ph.D., Division of Services and 
Intervention Research, National Institute of Mental Health, NIH, 
6001 Executive Boulevard, Room 6184, MSC 9617, Bethesda, Maryland 
20892, E-mail: [email protected], Phone: (301) 443-5944.
    Any member of the public interested in presenting oral comments 
to the Committee may notify the contact person listed on this notice 
at least 5 days in advance of the meeting. Interested individuals 
and representatives of organizations may submit a letter of intent, 
a brief description of the organization represented, and a short 
description of the oral presentation. Presentations may be limited 
to 5 minutes; both printed and electronic copies are requested for 
the record. In addition, any interested person may file written 
comments

[[Page 56725]]

with the Committee by forwarding his/her statement to the contact 
person listed on this notice. The statement should include the name, 
address, telephone number, and, when applicable, the business or 
professional affiliation of the interested person.
    Information about the meeting and online registration forms are 
also available online on the NIMH homepage at http://www.nimh.nih.gov/autismiacc/index.cfm.

    Dated: September 21, 2005.
Raynard S. Kington,
Deputy Director, National Institutes of Health.

[FR Doc. 05-19377 Filed 9-27-05; 8:45 am]
BILLING CODE 4140-01-P